BMRN
Asset Logo

BioMarin Pharmaceutical Inc.

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-1.88%
Annual Growth

5 years average annual growth

🌏

1
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company, which is engaged in developing and commercializing therapies that address the root cause of genetic conditions. BioMarin's commercial products include Vimizim (elosulfase alpha), Naglazyme (galsulfase), Palynziq (pegvaliase-pqpz), Brineura (cerliponase alfa), Aldurazyme (laronidase), Roctavian (valoctocogene roxaparvovec), Kuvan (sapropterin dihydrochloride), and Voxzogo (vosoritide). Vimizim is an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder. The Roctavian is an adeno associated virus (AAV5) vector gene therapy designed to restore factor VIII plasma concentrations in patients with severe hemophilia A. Voxzogo is a once daily injection analog of C-type Natriuretic Peptide (CNP) for the treatment of achondroplasia. Brineura is a recombinant human tripeptidyl peptidase 1 (TPP1) for the treatment of patients with CLN2, a form of Batten disease.

📈 Performance

Price History*

-20.19%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$66.60

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in BMRN

1

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

31 weeks

💵 Average investment amount

$1,038

Last time a customer invested in BMRN

198 days
BMRN investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

100%

Less than 50k

👶 Age of investors

18 - 25

26 - 34

100%

35 - 90

🙋 Legal gender of investors

Female

Male

100%

Pearlers who invest in BMRN also invest in...

Intellia Therapeutics Inc.

NTLA

🙌 Performance (5Yr p.a)

3.18%

📊 Share price

$14.81 USD
Find Out More

🙌 Performance (5Yr p.a)

36.79%

📊 Share price

$410.37 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

1.20%

📊 Share price

$81.35 USD

🙌 Performance (5Yr p.a)

17.19%

📊 Share price

$524.95 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

52.16%

📊 Share price

$192.95 USD

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-10.67%

📊 Share price

$4.75 USD

🙌 Performance (5Yr p.a)

-10.06%

📊 Share price

$22.14 USD
Compare
Add to watchlist